| The need for translational research on drug-drug interactions. | |
| | |
MedLine Citation:
|
PMID: 22513312 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Drug-drug interactions (DDIs) are an important clinical and public health concern. Although DDI screening now occurs during drug development, it is difficult to predict clinical importance based on in vitro experiments. Furthermore, older drugs that were not screened may have interactions that have not yet been identified. In this Commentary, we review the importance of DDIs and argue that a translational research approach is needed to produce clinically actionable information as well as generalizable biological knowledge. |
| | |
Authors:
|
S Hennessy; D A Flockhart |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical pharmacology and therapeutics Volume: 91 ISSN: 1532-6535 ISO Abbreviation: Clin. Pharmacol. Ther. Publication Date: 2012 May |
Date Detail:
|
Created Date: 2012-04-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372741 Medline TA: Clin Pharmacol Ther Country: United States |
Other Details:
|
Languages: eng Pagination: 771-3 Citation Subset: AIM; IM |
Affiliation:
|
Center for Clinical Epidemiology, Department of Biostatistics and Epidemiology, Department of Pharmacology, and Institute for Translational Medicine and Therapeutics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Using models to predict the future: what to do when the data run out?
Next Document: Clopidogrel: a case for indication-specific pharmacogenetics.